Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Postoperative Urinary Retention Management in the Post Anesthesia Care Unit (GEREMIS)

12 de junho de 2026 atualizado por: Florence GIMBERT, European Georges Pompidou Hospital

GEstion de la REprise MIctionnelle en Salle de Surveillance Post-interventionnelle/ Management of Postoperative Urinary Void Recovery in the Post-Anesthesia Care Unit

Introduction : The post-anesthesia care unit (PACU) admits patients in the immediate post-operative period in order to ensure monitoring, prevention, and management of early complications related to anesthesia and surgery. Post-operative urinary retention (POUR), inability to urinate despite a full bladder, is a common complication. Its incidence, causes, contributing factors, and complications have been the subject of numerous studies. Although well known, this complication has never had a consensus definition, particularly in terms of bladder volume, and the clinical signs known in urology are not always present post-operatively, notably pain and a feeling of fullness. In the event of POUR, bladder catheterization (intermittent catheterization, indwelling catheter placement, or suprapubic catheter) is often unavoidable, even though some studies have explored the possibility of pharmacological treatment. This procedure is invasive and carries its own risks: infection, trauma, bleeding, pain, discomfort, and loss of privacy/dignity. The challenge is to monitor and manage the onset of POUR while limiting unnecessary catheterization. For this purpose, bladder ultrasound is recommended to measure bladder volume. Previously performed by physicians using medical ultrasound machines, the arrival on the market of portable bladder scanners, which are non-invasive and simple to use, has made it possible to extend this examination to nurses. This diagnostic tool is a valuable aid in cases of suspected POUR (presence of clinical signs) or for patients at risk of obstruction. It helps guide medical decision-making regarding bladder catheterization. These devices, which have been available on the market for about thirty years, have gradually been adopted by care units, likely limited by the cost of investment. The PACUs of our institution have been equipped with this device for less than 7 years, with one of them having acquired it more recently, in 2025. Experienced staff members in the department have reported a sense that the use of the device varies among professionals, and that the number of intermittent catheterizations performed in the PACU has increased since the device was introduced. In this context, we wish to evaluate our practices regarding the management of post-operative urinary voiding recovery, the appropriateness of bladder scanner uses in the PACU, and the appropriateness of bladder catheterization decisions. This project will describe practices regarding the management of urinary voiding recovery, analyze the appropriateness of bladder catheterizations, and help understand the clinical reasoning of healthcare staff. It is part of paramedical research on the evolution of practices with decision-support technologies.

Methods: A nursing observational study on care practices, Single-center, mixed-methods study (prospective and retrospective), using data collected as part of routine care for the quantitative analysis and a practice survey by questionnaire addressed to healthcare staff for the qualitative analysis. Data will be collected as part of routine care from medical records (PACU monitoring sheet and electronic patient record) and from a study-specific data collection form for the prospective component, allowing further detail on the modalities of nursing care. Data will be collected over the period between admission to the PACU and the 24 hours following discharge from the PACU. The medical records of 970 patients will be analyzed (485 retrospectively and 485 prospectively). In addition, an anonymous questionnaire will be given to nursing staff working in the PACU, to explore current knowledge and practice habits.

Visão geral do estudo

Tipo de estudo

Observacional

Inscrição (Estimado)

970

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

  • Adulto
  • Adulto mais velho

Aceita Voluntários Saudáveis

Não

Método de amostragem

Amostra Não Probabilística

População do estudo

Patient admitted to the PACU for post-operative monitoring (excluding outpatient/ambulatory and endoscopy cases)

Descrição

Inclusion Criteria:

  • Patient admitted to the PACU for post-operative monitoring (excluding outpatient/ambulatory and endoscopy cases)
  • Standard post-operative monitoring (transfer to a surgical ward after the monitoring period)
  • Adult patient (≥18 years)

Exclusion Criteria:

  • Post-operative care following urological surgery
  • History of chronic urinary retention
  • Presence of an indwelling urinary drainage system upon arrival in the PACU (urinary catheter, Bricker ileal conduit, suprapubic catheter)
  • Chronic renal failure requiring dialysis
  • Transfer to intensive care after the PACU monitoring period
  • Patient under legal protection (guardianship/conservatorship)

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Evaluate the incidence of potentially avoidable urinary catheterizations performed post-operatively in the PACU.
Prazo: 24 hours
Proportion of catheterizations with an initial drained volume <500 mL among all urinary catheterizations performed in the PACU in included patients
24 hours

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Evaluate the appropriateness of bladder scanner use
Prazo: 24 hours
Proportion of patients having had at least one bladder scan measurement in the PACU. Description of urinary volumes measured by bladder scan (median/IQR). Proportion of measurements associated with the presence of clinical signs of urinary retention, and proportion of measurements associated with the presence of factors contributing to retention
24 hours
Analyze post-operative urinary voiding recovery and its modalities
Prazo: 24 hours
Proportion of patients with voiding recovery in the PACU, proportion of patients with voiding recovery upon return to the surgical ward, by modality of voiding recovery: voluntary or prompted by staff (prospective component).
24 hours
Measure the rate of intermittent catheterizations and the average volume drained
Prazo: 24 hours
Proportion of patients who underwent intermittent catheterization in the PACU, proportion of patients who underwent intermittent catheterization upon return to the surgical ward, description of drained volumes (median/IQR).
24 hours
Evaluate the decision criteria for intermittent catheterization (prospective component)
Prazo: 24 hours
Among catheterized patients: proportion of patients with presence/absence of clinical signs of POUR, proportion of patients with a prior bladder scan measurement, description of the median/IQR bladder scan volume
24 hours
Evaluate the correlation between the bladder catheterization rate and length of stay in the PACU (prospective component)
Prazo: 24 hours
Median length of stay in the PACU among patients who required catheterization and among patients who did not require catheterization
24 hours
Analyze staff clinical reasoning (questionnaire)
Prazo: 24 hours
Description of the decision criteria for catheterization, decision criteria for bladder scan use, and management of voiding.
24 hours

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Estimado)

12 de junho de 2026

Conclusão Primária (Estimado)

28 de agosto de 2026

Conclusão do estudo (Estimado)

29 de agosto de 2026

Datas de inscrição no estudo

Enviado pela primeira vez

12 de junho de 2026

Enviado pela primeira vez que atendeu aos critérios de CQ

12 de junho de 2026

Primeira postagem (Real)

18 de junho de 2026

Atualizações de registro de estudo

Última Atualização Postada (Real)

18 de junho de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

12 de junho de 2026

Última verificação

1 de junho de 2026

Mais Informações

Termos relacionados a este estudo

Outros números de identificação do estudo

  • IRB 00010254 - 2026 - 084

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever